US Bancorp’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $132K | Buy |
2,970
+667
| +29% | +$31.6K | ﹤0.01% | 2310 |
|
|
2026
Q1 | $119K | Sell |
2,303
-863
| -27% | -$60.4K | ﹤0.01% | 2294 |
|
|
2025
Q4 | $292K | Buy |
3,166
+387
| +14% | +$37K | ﹤0.01% | 1836 |
|
|
2025
Q3 | $206K | Buy |
2,779
+736
| +36% | +$74.5K | ﹤0.01% | 1983 |
|
|
2025
Q2 | $265K | Sell |
2,043
-436
| -18% | -$63.2K | ﹤0.01% | 1872 |
|
|
2025
Q1 | $395K | Buy |
2,479
+143
| +6% | +$25.9K | ﹤0.01% | 1620 |
|
|
2024
Q4 | $433K | Buy |
2,336
+820
| +54% | +$159K | ﹤0.01% | 1571 |
|
|
2024
Q3 | $320K | Sell |
1,516
-89
| -6% | -$15.5K | ﹤0.01% | 1772 |
|
|
2024
Q2 | $215K | Sell |
1,605
-134
| -8% | -$25.4K | ﹤0.01% | 1968 |
|
|
2024
Q1 | $374K | Sell |
1,739
-492
| -22% | -$96.4K | ﹤0.01% | 1673 |
|
|
2023
Q4 | $454K | Buy |
2,231
+689
| +45% | +$112K | ﹤0.01% | 1565 |
|
|
2023
Q3 | $306K | Buy |
1,542
+884
| +134% | +$223K | ﹤0.01% | 1625 |
|
|
2023
Q2 | $214K | Buy |
658
+88
| +15% | +$25.1K | ﹤0.01% | 1834 |
|
|
2023
Q1 | $133K | Sell |
570
-369
| -39% | -$93.3K | ﹤0.01% | 2053 |
|
|
2022
Q4 | $237K | Sell |
939
-1,225
| -57% | -$261K | ﹤0.01% | 1773 |
|
|
2022
Q3 | $384K | Buy |
2,164
+56
| +3% | +$11.3K | ﹤0.01% | 1520 |
|
|
2022
Q2 | $385K | Sell |
2,108
-176
| -8% | -$35.1K | ﹤0.01% | 1569 |
|
|
2022
Q1 | $586K | Buy |
2,284
+231
| +11% | +$52.8K | ﹤0.01% | 1461 |
|
|
2021
Q4 | $472K | Sell |
2,053
-81
| -4% | -$19.8K | ﹤0.01% | 1551 |
|
|
2021
Q3 | $497K | Sell |
2,134
-53
| -2% | -$11.1K | ﹤0.01% | 1520 |
|
|
2021
Q2 | $423K | Buy |
2,187
+151
| +7% | +$29.9K | ﹤0.01% | 1631 |
|
|
2021
Q1 | $421K | Sell |
2,036
-120
| -6% | -$25.5K | ﹤0.01% | 1589 |
|
|
2020
Q4 | $405K | Sell |
2,156
-178
| -8% | -$29.1K | ﹤0.01% | 1552 |
|
|
2020
Q3 | $301K | Buy |
2,334
+1,500
| +180% | +$165K | ﹤0.01% | 1588 |
|
|
2020
Q2 | $73K | Hold |
834
| – | – | ﹤0.01% | 2254 |
|
|
2020
Q1 | $50K | Hold |
834
| – | – | ﹤0.01% | 2361 |
|
|
2019
Q4 | $62K | Hold |
834
| – | – | ﹤0.01% | 2369 |
|
|
2019
Q3 | $51K | Hold |
834
| – | – | ﹤0.01% | 2456 |
|
|
2019
Q2 | $51K | Hold |
834
| – | – | ﹤0.01% | 2517 |
|
|
2019
Q1 | $47K | Hold |
834
| – | – | ﹤0.01% | 2517 |
|
|
2018
Q4 | $35K | Hold |
834
| – | – | ﹤0.01% | 2605 |
|
|
2018
Q3 | $35K | Sell |
834
-833
| -50% | -$39.1K | ﹤0.01% | 2724 |
|
|
2018
Q2 | $59K | Buy |
+1,667
| New | +$53.8K | ﹤0.01% | 2495 |
|
Other funds holding INSP
SCM
DM
US Bancorp's INSP Position: Q2 2026 in Review
US Bancorp increased its Inspire Medical Systems (INSP) stake by 29% in Q2 2026, buying an estimated $31.6K and bringing the position to 2,970 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #2310.
US Bancorp first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $586K in Q1 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- US Bancorp held 2,970 shares of Inspire Medical Systems worth $132K as of Q2 2026.
- US Bancorp bought 667 Inspire Medical Systems shares in Q2 2026, an estimated $31.6K.
- Inspire Medical Systems made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2310 holding.
- US Bancorp first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- US Bancorp's Inspire Medical Systems position peaked at $586K in Q1 2022.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.